Despite the relevance of these approaches as in vivo models for templated Tau aggregation, they do not reflect the situation in sporadic AD patients, where non-mutant Tau aggregates first in the EC and from there progresses to other brain regions. This evidence concerns the gene MAPT and Alzheimer disease.